About Brenton Saunders
Brenton Saunders is a board director at Cambrian BioPharma.
Brenton Saunders first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Brenton Saunders in the role, so the role may have started earlier or lasted longer.
Cambrian BioPharma Inc
Board Director
2023 – 2026 · New York, NY
Develops medicines targeting metabolic decline and related chronic diseases.
Key Colleagues at Startups
The people Brenton Saunders works with at each company, as listed on that company's latest Form D.
Cambrian BioPharma Inc · Form D, Jul 15, 2026

James Peyer
CEO, Founder, Board Director
MN
Mark Nuttall
Executive officer
CA
Christian Angermeyer
Director
MG
Martin Gunhaga
Director
JH
Juliette Han
Executive officer and director

Maryanna Saenko
Board Director
RE
Ruth Thieroff-Ekerdt
Executive officer
WD
William DeVaul
Chief Legal Officer
LN
Lorin Van Nuland
Director
-modified.png)
Paul Farr
Board Director
-modified.png)